Display options
Share it on

Cent Eur J Immunol. 2019;44(1):92-96. doi: 10.5114/ceji.2019.83615. Epub 2019 Apr 15.

Investigations of cellular immunity in juvenile idiopathic arthritis.

Central-European journal of immunology

Lucia Maria Sur, Genel Sur, Gabriel Samasca, Iulia Lupan

Affiliations

  1. Department of Paediatrics I, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  2. Department of Paediatrics II, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  3. Department of Immunology, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  4. Department of Molecular Biology, "Babes-Bolyai" University, Cluj-Napoca, Romania.

PMID: 31114442 PMCID: PMC6526591 DOI: 10.5114/ceji.2019.83615

Abstract

The following was emphasised in an informative, educational issued on the American College of Rheumatology website in April 2017: "About one child in every 1000 develops some type of chronic arthritis. These disorders can affect children at any age, although rarely in the first six months of life. It is estimated that around 300,000 children in the United States have been diagnosed with the condition". Therefore, knowledge of immunological investigations in patients with juvenile idiopathic arthritis is important for finding new treatment pathways. Our aim was to assess the immunological investigations and immune system implications in juvenile idiopathic arthritis. We will discuss: a) the specifically targeted proteins - the citrullinated peptide antibodies; b) non-specifically targeted proteins - heat-shock proteins (anti-HSP60, -65, and -70 antibodies), CLEC16A, inflammasomes, and phagocyte-derived S100; c) interleukins - IL-1, IL-6, IL-10, IL-17, and IL-18; d) innate immunity - macrophage activation syndrome, natural killer cells, complement activity, and immune complexes; and e) therapeutic targets - monoclonal antibodies, JAK inhibitors, and intravenous immune globulin.

Keywords: immunological targets; immunopathology; juvenile idiopathic arthritis

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Autoimmunity. 2002 Sep;35(6):397-401 - PubMed
  2. J Autoimmun. 2006 Sep;27(2):81-8 - PubMed
  3. Scand J Immunol. 2007 Jan;65(1):76-83 - PubMed
  4. Clin Rev Allergy Immunol. 2007 Feb;32(1):47-56 - PubMed
  5. Immunology. 2007 Oct;122(2):291-301 - PubMed
  6. Autoimmun Rev. 2008 Feb;7(4):305-8 - PubMed
  7. J Immunoassay Immunochem. 2008;29(3):281-98 - PubMed
  8. Immunol Invest. 2008;37(8):849-57 - PubMed
  9. J Autoimmun. 2009 Nov-Dec;33(3-4):208-13 - PubMed
  10. Genes Immun. 2010 Sep;11(6):504-8 - PubMed
  11. Clin Immunol Immunopathol. 1991 Aug;60(2):232-43 - PubMed
  12. Autoimmun Rev. 2011 Jun;10(8):482-9 - PubMed
  13. Genes Immun. 2012 Jun;13(4):289-98 - PubMed
  14. Nat Rev Immunol. 2012 Jul 25;12(8):570-80 - PubMed
  15. Clin Immunol. 2013 Jun;147(3):229-41 - PubMed
  16. Hum Immunol. 2013 Aug;74(8):986-92 - PubMed
  17. Semin Immunol. 2014 Feb;26(1):97-104 - PubMed
  18. Semin Immunol. 2014 Feb;26(1):88-96 - PubMed
  19. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48 - PubMed
  20. Cytokine Growth Factor Rev. 2015 Feb;26(1):35-45 - PubMed
  21. Int Immunol. 2015 Jan;27(1):21-9 - PubMed
  22. Expert Rev Clin Immunol. 2014 Nov;10(11):1427-35 - PubMed
  23. Clin Rev Allergy Immunol. 2015 Oct;49(2):253-61 - PubMed
  24. J Immunol Res. 2015;2015:915276 - PubMed
  25. Expert Rev Clin Immunol. 2015 May;11(5):575-88 - PubMed
  26. Autoimmun Rev. 2015 Aug;14(8):651-8 - PubMed
  27. Autoimmun Rev. 2015 Sep;14(9):769-73 - PubMed
  28. Clin Immunol. 2015 Jul;159(1):72-83 - PubMed
  29. Semin Immunopathol. 2015 Jul;37(4):387-94 - PubMed
  30. Immunity. 2015 May 19;42(5):942-52 - PubMed
  31. J Autoimmun. 2015 Jul;61:1-8 - PubMed
  32. Semin Immunopathol. 2015 Jul;37(4):403-6 - PubMed
  33. Clin Immunol. 2015 Oct;160(2):277-81 - PubMed
  34. Clin Immunol. 2015 Dec;161(2):163-9 - PubMed
  35. Expert Rev Clin Immunol. 2015;11 Suppl 1:S5-14 - PubMed
  36. Eur J Immunol. 2016 Feb;46(2):269-80 - PubMed
  37. Immunotherapy. 2016;8(1):79-87 - PubMed
  38. Immunotherapy. 2016 Feb;8(2):127-33 - PubMed
  39. Cent Eur J Immunol. 2015;40(4):470-6 - PubMed
  40. Clin Immunol. 2016 Apr;165:21-8 - PubMed
  41. Bratisl Lek Listy. 2016;117(5):258-62 - PubMed
  42. Front Immunol. 2016 May 20;7:177 - PubMed
  43. Clin Immunol. 2016 Aug;169:8-13 - PubMed
  44. Clin Rev Allergy Immunol. 2018 Jun;54(3):375-385 - PubMed
  45. Front Immunol. 2016 Jun 13;7:203 - PubMed
  46. Eur J Immunol. 2016 Sep;46(9):2068-77 - PubMed
  47. Immunology. 2016 Oct;149(2):131-8 - PubMed
  48. J Autoimmun. 2017 Feb;77:55-66 - PubMed
  49. J Clin Rheumatol. 2016 Dec;22(8):446-448 - PubMed
  50. Ital J Pediatr. 2017 Jan 17;43(1):9 - PubMed
  51. Expert Opin Drug Saf. 2017 Apr;16(4):493-500 - PubMed
  52. Expert Opin Investig Drugs. 2017 Apr;26(4):381-387 - PubMed
  53. Vestn Oftalmol. 2017;133(1):27-31 - PubMed
  54. Arthritis Rheumatol. 2017 Jul;69(7):1480-1494 - PubMed
  55. F1000Res. 2017 Jun 22;6:971 - PubMed
  56. Harefuah. 2017 Jul;156(7):427-430 - PubMed
  57. J Clin Lab Immunol. 1988 Mar;25(3):115-8 - PubMed
  58. Clin Exp Immunol. 1995 Jun;100(3):514-8 - PubMed
  59. J Clin Immunol. 1995 Nov;15(6 Suppl):42S-51S - PubMed
  60. Semin Immunol. 1998 Feb;10(1):35-41 - PubMed

Publication Types